基于甲基化的鳞状细胞癌原发部位跨平台分类器
本研究开发了SquaMOS甲基化分类器,用于预测鳞状外观癌的原发部位。基于1062例原发鳞癌和尿路上皮癌的阵列甲基化数据训练,在内外部测试集中准确率分别为96.1%和97.4%,转移瘤中达96.1%,并可适用于低深度Nanopore测序数据。
要点
- SquaMOS可高准确度区分鳞癌原发部位及与尿路上皮癌的鉴别。
- 在转移瘤中预测准确率达96.1%,支持临床转移灶溯源。
- 可迁移至低深度Nanopore测序,高置信预测准确率100%。
核心结论
- SquaMOS分类器在原发和转移性鳞状外观癌中均展现高准确度的原发部位预测能力。
研究设计与样本
- 基于公共阵列甲基化数据训练,纳入1062例原发鳞癌(肺、头颈、宫颈、食管)和尿路上皮癌。
主要发现
- 内部测试集(n=458)准确率96.1%,外部测试集(3机构,n=78)准确率97.4%。
- 转移瘤(n=51)预测准确率96.1%。
- Nanopore浅测序数据(CpG探针位点覆盖0.25-2.88×)准确率91.7%(n=36),高置信预测准确率100%。
- 训练集类型外的SCC(n=15,含3例肺转移)无病例被误判为肺来源。
临床怎么用
- 可用于原发与转移性鳞状肿瘤的溯源鉴别,辅助临床管理决策。
- 基于阵列的分类器可迁移至低深度Nanopore测序,有望实现快速原发部位判定。
局限性
- 对训练集类型外的SCC类型验证样本量有限(n=15)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Squamous cell carcinomas (SCCs) are one of the most common cancer types and can arise at nearly any anatomic site. Because SCCs are one of the most common metastases, do not have reliable site-specific morphologic or genomic features, and have considerable morphologic and immunohistochemical overlap with urothelial carcinomas, distinguishing between primary and metastatic squamous-appearing tumors can be challenging. This distinction can be critical to clinical management. We present Squamous cell carcinoma Methylation for Origin Site (SquaMOS), a methylation-based classifier to predict site of origin of squamous-appearing carcinomas. Trained on publicly available array-based methylation data from 1062 primary SCCs (from lung, head and neck, cervix, and esophagus) and urothelial carcinomas, SquaMOS predicted site of origin in primary tumors with 96.1% accuracy in an internal test set (n = 458) and 97.4% accuracy in an external test set from 3 institutions (n = 78). On metastatic tumors (n = 51), SquaMOS predictions were 96.1% accurate. SquaMOS was directly applicable to shallow Nanopore sequencing data (CpG probe site coverage, 0.25-2.88×) with an accuracy of 91.7% (n = 36; 100% accurate for high-confidence predictions). When tested on SCCs outside the training set types (n = 15, including 3 metastases to lung), no cases were misclassified as of lung origin, supporting accuracy of lung vs nonlung origin classification for diverse SCC types. Overall, we demonstrate highly accurate performance of the SquaMOS classifier on primary and metastatic tumors from multiple data sources, robust to suboptimal tumor purity. We illustrate transferability of our array-based classifier to low-depth Nanopore sequencing data, a potentially rapid means of site of origin determination in a clinical setting.
引用
- Zhang AW, Akbari V, Galbraith A, et al. Cross-Platform Methylation-Based Site of Origin Classification for Squamous Cell Carcinomas. Mod Pathol. 2025. PMID: 40902853. doi:10.1016/j.modpat.2025.100878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。